177 related articles for article (PubMed ID: 25539763)
1. ALCAM is indirectly modulated by miR-125b in MCF7 cells.
Akman HB; Selcuklu SD; Donoghue MT; Akhavantabasi S; Sapmaz A; Spillane C; Yakicier MC; Erson-Bensan AE
Tumour Biol; 2015 May; 36(5):3511-20. PubMed ID: 25539763
[TBL] [Abstract][Full Text] [Related]
2. MiR-148a and miR-152 reduce tamoxifen resistance in ER+ breast cancer via downregulating ALCAM.
Chen MJ; Cheng YM; Chen CC; Chen YC; Shen CJ
Biochem Biophys Res Commun; 2017 Feb; 483(2):840-846. PubMed ID: 28063929
[TBL] [Abstract][Full Text] [Related]
3. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients.
Burandt E; Bari Noubar T; Lebeau A; Minner S; Burdelski C; Jänicke F; Müller V; Terracciano L; Simon R; Sauter G; Wilczak W; Lebok P
Oncol Rep; 2014 Dec; 32(6):2628-34. PubMed ID: 25270339
[TBL] [Abstract][Full Text] [Related]
4. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis.
Davies S; Jiang WG
Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
6. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling and the role of ALCAM modulating tumor growth and metastasis in benzo[a]pyrene-transformed 16HBE cells.
Li L; Chen J; Wang Y; Zhou C; Ma X; Fu J; Yao B; Zhao P
Toxicology; 2020 Sep; 442():152539. PubMed ID: 32681969
[TBL] [Abstract][Full Text] [Related]
8. [Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy].
Kilic E; Milde-Langosch K; Müller V; Wirtz R; Ihnen M
Pathologe; 2008 Nov; 29 Suppl 2():347-52. PubMed ID: 18810438
[TBL] [Abstract][Full Text] [Related]
9. miR-214 and miR-148b Targeting Inhibits Dissemination of Melanoma and Breast Cancer.
Orso F; Quirico L; Virga F; Penna E; Dettori D; Cimino D; Coppo R; Grassi E; Elia AR; Brusa D; Deaglio S; Brizzi MF; Stadler MB; Provero P; Caselle M; Taverna D
Cancer Res; 2016 Sep; 76(17):5151-62. PubMed ID: 27328731
[TBL] [Abstract][Full Text] [Related]
10. miR-125b targets ARID3B in breast cancer cells.
Akhavantabasi S; Sapmaz A; Tuna S; Erson-Bensan AE
Cell Struct Funct; 2012; 37(1):27-38. PubMed ID: 22307404
[TBL] [Abstract][Full Text] [Related]
11. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
[TBL] [Abstract][Full Text] [Related]
12. The carboxy-terminal domain of connexin 43 (CT-Cx43) modulates the expression of p53 by altering miR-125b expression in low-grade human breast cancers.
Maqbool R; Rashid R; Ismail R; Niaz S; Chowdri NA; Hussain MU
Cell Oncol (Dordr); 2015 Dec; 38(6):443-51. PubMed ID: 26335100
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of miR-630 Induced by Oxidative Damage Resists Cell Migration Through Targeting ALCAM in Human Lens Epithelium Cells.
Mei L; Yan H; Wang S; Guo C; Zheng X; Yan B; Zhao J; Yang A
Curr Eye Res; 2020 Feb; 45(2):153-161. PubMed ID: 31869263
[No Abstract] [Full Text] [Related]
14. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
15. Detection of activated leukocyte cell adhesion molecule in the serum of breast cancer patients and implications for prognosis.
Witzel I; Schröder C; Müller V; Zander H; Tachezy M; Ihnen M; Jänicke F; Milde-Langosch K
Oncology; 2012; 82(6):305-12. PubMed ID: 22555284
[TBL] [Abstract][Full Text] [Related]
16. The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.
Xie X; Hu Y; Xu L; Fu Y; Tu J; Zhao H; Zhang S; Hong R; Gu X
Tumour Biol; 2015 Sep; 36(9):7185-94. PubMed ID: 25894378
[TBL] [Abstract][Full Text] [Related]
17. Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer.
Ihnen M; Müller V; Wirtz RM; Schröder C; Krenkel S; Witzel I; Lisboa BW; Jänicke F; Milde-Langosch K
Breast Cancer Res Treat; 2008 Dec; 112(3):419-27. PubMed ID: 18172759
[TBL] [Abstract][Full Text] [Related]
18. miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation.
Penna E; Orso F; Cimino D; Vercellino I; Grassi E; Quaglino E; Turco E; Taverna D
Cancer Res; 2013 Jul; 73(13):4098-111. PubMed ID: 23667173
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Activated Leucocyte Cell Adhesion Molecule (ALCAM/CD166) in Infantile Neuroblastoma.
Wachowiak R; Mayer S; Kaifi J; Gebauer F; Izbicki JR; Lacher M; Bockhorn M; Tachezy M
Anticancer Res; 2016 Aug; 36(8):3991-5. PubMed ID: 27466504
[TBL] [Abstract][Full Text] [Related]
20. miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.
Feliciano A; Castellvi J; Artero-Castro A; Leal JA; Romagosa C; Hernández-Losa J; Peg V; Fabra A; Vidal F; Kondoh H; Ramón Y Cajal S; Lleonart ME
PLoS One; 2013; 8(10):e76247. PubMed ID: 24098452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]